Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head

References

• Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine 41(2), 183–190 (2011).
   PubMed Web of Science ®Google Scholar
• Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol. Metab. Clin. North Am. 41(3), 595–611 (2012).
   PubMed Web of Science ®Google Scholar
• Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin. Drug Saf. 15(4), 457–465 (2016).
   PubMed Web of Science ®Google Scholar
• Luo P, Gao F, Han J, Sun W, Li Z. The role of autophagy in steroid necrosis of the femoral head: a comprehensive research review. Int. Orthop. 42(7), 1747–1753 (2018).
   PubMed Web of Science ®Google Scholar
• Zhao DW, Yu M, Hu K et al. Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population: results from a nationally representative survey. Chin. Med. J. (Engl.) 128(21), 2843–2850 (2015).
   PubMed Web of Science ®Google Scholar
• Gou W, Lu Q, Wang X, Wang Y, Peng J, Lu S. Key pathway to prevent the collapse of femoral head in osteonecrosis. Eur. Rev. Med. Pharmacol. Sci. 19(15), 2766–2774 (2015).
   PubMed Web of Science ®Google Scholar
• Liang X-Z, Luo D, Chen Y-R et al. Identification of potential autophagy-related genes in steroid-induced osteonecrosis of the femoral head via bioinformatics analysis and experimental verification. J. Orthop. Surg. Res. 17(1), 86 (2022).
   PubMed Web of Science ®Google Scholar
• Hadjigeorgiou G, Dardiotis E, Dardioti M, Karantanas A, Dimitroulias A, Malizos K. Genetic association studies in osteonecrosis of the femoral head: mini review of the literature. Skeletal Radiol. 37(1), 1–7 (2008).
   PubMed Web of Science ®Google Scholar
• Du J, Liu W, Jin T et al. A single-nucleotide polymorphism in MMP9 is associated with decreased risk of steroid-induced osteonecrosis of the femoral head. Oncotarget 7(42), 68434–68441 (2016).
   PubMedGoogle Scholar
• Du J, Jin T, Cao Y et al. Association between genetic polymorphisms of MMP8 and the risk of steroid-induced osteonecrosis of the femoral head in the population of northern China. Medicine (Baltimore) 95(37), e4794 (2016).
   PubMed Web of Science ®Google Scholar
• Wang Z, Gerstein M, Snyder M. RNA-seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10(1), 57–63 (2009).
   PubMed Web of Science ®Google Scholar
• Yang J, Jing M, Yang X. Association between genetic polymorphisms and osteonecrosis in steroid treatment populations: a detailed stratified and dose–response meta-analysis. Biosci. Rep. 39(5), BSR20190024 (2019).
   PubMedGoogle Scholar
• Li Z, Jiang C, Li X et al. Circulating microRNA signature of steroid-induced osteonecrosis of the femoral head. Cell Prolif. 51(1), e12418 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang C, Liu Z et al. Screening of potential biomarkers in the peripheral serum for steroid-induced osteonecrosis of the femoral head based on WGCNA and machine learning algorithms. Dis. Markers 2022, 1–17 (2022).
   Web of Science ®Google Scholar
• Luo H, Lan W, Li Y et al. Microarray analysis of long-noncoding RNAs and mRNA expression profiles in human steroid-induced avascular necrosis of the femoral head. J. Cell. Biochem. 120(9), 15800–15813 (2019).
   PubMed Web of Science ®Google Scholar
• Zhu Z, Du W, Yu H, Jin H, Tong P. Expression profile analysis of differentially expressed circular RNAs in steroid-induced osteonecrosis of the femoral head. Dis. Markers 2019, 1–10 (2019).
   Web of Science ®Google Scholar
• Yao T, Yin Z-S, Huang W, Ding Z-F, Cheng C. Microarray profiling of circular RNAs in steroid-associated osteonecrosis of the femoral head. Medicine (Baltimore) 99(10), e19465 (2020).
   PubMed Web of Science ®Google Scholar
• Shakhawat HM, Hazrat Z, Zhou Z. Isthmin – a multifaceted protein family. Cells 12(1), 17 (2022).
   PubMed Web of Science ®Google Scholar
• Xiang W, Ke Z, Zhang Y et al. Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice. J. Cell. Mol. Med. 15(2), 359–374 (2011).
   PubMed Web of Science ®Google Scholar
• Yuan B, Xian R, Ma J, Chen Y, Lin C, Song Y. Isthmin inhibits glioma growth through antiangiogenesis in vivo. J. Neurooncol. 109(2), 245–252 (2012).
   PubMed Web of Science ®Google Scholar
• Jiang Z, Zhao M, Voilquin L et al. Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis. Cell Metab. 33(9), 1836–1852.e11 (2021).
   PubMed Web of Science ®Google Scholar
• Ruiz-Ojeda FJ, Anguita-Ruiz A, Rico MC et al. Serum levels of the novel adipokine isthmin-1 are associated with obesity in pubertal boys. World J. Pediatr. 19(9), 864–872 (2023).
   PubMed Web of Science ®Google Scholar
• Fang X, Zuo J, Zhou J et al. Childhood obesity leads to adult type 2 diabetes and coronary artery diseases. Medicine (Baltimore) 98(32), e16825 (2019).
   PubMed Web of Science ®Google Scholar
• Li C, Zhong S, Ni S, Liu Z, Zhang S, Ji G. Zebrafish Ism1 is a novel antiviral factor that positively regulates antiviral immune responses. Dev. Comp. Immunol. 125, 104210 (2021).
   PubMed Web of Science ®Google Scholar
• Kao C, Chandna R, Ghode A et al. Proapoptotic cyclic peptide BC71 targets cell-surface GRP78 and functions as an anticancer therapeutic in mice. EBioMedicine 33, 22–32 (2018).
   PubMed Web of Science ®Google Scholar
• Yoshitomi R, Nakayama K, Yamashita S et al. Plasma homocysteine concentration is associated with the expression level of folate receptor 3. Sci. Rep. 10(1), 10283 (2020).
   PubMedGoogle Scholar
• Behera J, Bala J, Nuru M, Tyagi SC, Tyagi N. Homocysteine as a pathological biomarker for bone disease. J. Cell. Physiol. 232(10), 2704–2709 (2017).
   PubMed Web of Science ®Google Scholar
• Narayanan A, Khanchandani P, Borkar RM et al. Avascular necrosis of femoral head: a metabolomic, biophysical, biochemical, electron microscopic and histopathological characterization. Sci. Rep. 7(1), 10721 (2017).
   PubMedGoogle Scholar
• Naik AA, Narayanan A, Khanchandani P et al. Systems analysis of avascular necrosis of femoral head using integrative data analysis and literature mining delineates pathways associated with disease. Sci. Rep. 10(1), 18099 (2020).
   PubMed Web of Science ®Google Scholar
• Hernández-Zamora E, Rodríguez-Olivas AO, Rosales-Cruz E, Galicia-Alvarado MA, Zavala-Hernández C, Reyes-Maldonado E. Prothrombin time and coagulation factor IX as hemostatic risk markers for Legg–Calvé–Perthes disease. Clin. Appl. Thromb. Hemost. 29, 107602962211511 (2023).
   Web of Science ®Google Scholar
• Hager NA, McAtee CK, Lesko MA, O'Donnell AF. Inwardly rectifying potassium channel Kir2.1 and its ‘Kir-ious’ regulation by protein trafficking and roles in development and disease. Front. Cell Dev. Biol. 9, 796136 (2022).
   PubMed Web of Science ®Google Scholar
• Ozekin YH, Isner T, Bates EA. Ion channel contributions to morphological development: insights from the role of Kir2.1 in bone development. Front. Mol. Neurosci. 13, 99 (2020).
   PubMed Web of Science ®Google Scholar
• Belus MT, Rogers MA, Elzubeir A et al. Kir2.1 is important for efficient BMP signaling in mammalian face development. Dev. Biol. 444, S297–S307 (2018).
   PubMed Web of Science ®Google Scholar
• Lowery JW, Rosen V. The BMP pathway and its inhibitors in the skeleton. Physiol. Rev. 98(4), 2431–2452 (2018).
   PubMed Web of Science ®Google Scholar
• Pini J, Giuliano S, Matonti J et al. Osteogenic and chondrogenic master genes expression is dependent on the Kir2.1 potassium channel through the bone morphogenetic protein pathway. J. Bone Miner. Res. 33(10), 1826–1841 (2018).
   PubMed Web of Science ®Google Scholar